S20 - Access to critical medicines across Europe
Enhancing supply chain resilience and patient reach
Session description
With the launch of Critical Medicines Alliance earlier this year, in a context of supply chain vulnerability, this interactive discussion aims to focus on presenting comprehensive solutions to enhancing the resilience of the critical medicines supply chain and improving patient access to medicines across Europe.By fostering multi-stakeholder participation and dialogue, this session will provide an update on the progress made by the Critical Medicines Alliance to date, ahead of the expected Critical Medicines Act and policy toolbox. Attendees will gain insights into collaborative efforts, innovative strategies, and best practices that address the challenges of stakeholders' concerns, including pricing and reimbursement mechanisms, stockpiling, reshoring, and the impact of geopolitics.